acecainide has been researched along with Heart Failure in 3 studies
Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty Caucasian adult patients with ventricular tachycardia were treated with intravenous procainamide." | 7.67 | Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations. ( Bauer, LA; Black, D; Gensler, A; Sprinkle, J, 1989) |
| "Twenty Caucasian adult patients with ventricular tachycardia were treated with intravenous procainamide." | 3.67 | Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations. ( Bauer, LA; Black, D; Gensler, A; Sprinkle, J, 1989) |
| "Nineteen patients whose arrhythmias were initially suppressed with acetylprocainamide underwent long-term treatment with this drug." | 3.66 | Long-term antiarrhythmic therapy with acetylprocainamide. ( Drayer, DE; Kluger, J; Leech, S; Lloyd, V; Reidenberg, MM, 1981) |
| "Two patients with chronic renal failure developed transient sinus node dysfunction requiring insertion of a temporary pacemaker while receiving procainamide to control ventricular arrhythmias." | 3.66 | Procainamide-induced sinus node dysfunction in patients with chronic renal failure. ( Friedman, HS; Kim, HG, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kluger, J | 1 |
| Leech, S | 1 |
| Reidenberg, MM | 1 |
| Lloyd, V | 1 |
| Drayer, DE | 1 |
| Kim, HG | 1 |
| Friedman, HS | 1 |
| Bauer, LA | 1 |
| Black, D | 1 |
| Gensler, A | 1 |
| Sprinkle, J | 1 |
3 other studies available for acecainide and Heart Failure
| Article | Year |
|---|---|
Long-term antiarrhythmic therapy with acetylprocainamide.
Topics: Acecainide; Acetylation; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthritis, Rheum | 1981 |
Procainamide-induced sinus node dysfunction in patients with chronic renal failure.
Topics: Acecainide; Aged; Angina Pectoris; Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; Female; Hea | 1979 |
Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
Topics: Acecainide; Aged; Aging; Creatinine; Female; Heart Failure; Humans; Kidney; Kidney Diseases; Male; M | 1989 |